Development of bioconjugates for targeted tumor therapy of cancer types leading to high mortality  Page description

Help  Print 
Back »

 

Details of project

 
Identifier
119552
Type K
Principal investigator Mező, Gábor
Title in Hungarian Magas mortalitású daganatos megbetegedések irányított tumorterápiás kezelésére alkalmas biokonjugátumok fejlesztése
Title in English Development of bioconjugates for targeted tumor therapy of cancer types leading to high mortality
Keywords in Hungarian irányított tumorterápia, peptid hordozók. tumorellenes hatóanyagok, fág-könyvtárak, melanóma, tüdőrák, hasnyálmirigyrák, agytumorok
Keywords in English targeted tumor therapy, peptide carrier, anticancer drugs, phage display libraries, melanoma, lung cancer, pancreatic cancer, brain cancer
Discipline
Organic, Biomolecular, and Pharmaceutical Chemistry (Council of Physical Sciences)70 %
Ortelius classification: Pharmaceutical chemistry
Organic, Biomolecular, and Pharmaceutical Chemistry (Council of Physical Sciences)15 %
Cancer and its biological basis (Council of Medical and Biological Sciences)15 %
Panel Chemistry 2
Department or equivalent Research Group for Peptide Chemistry (Eötvös Loránd University)
Participants Bánóczi, Zoltán
Biri, Beáta
Bősze, Szilvia
Enyedi, Kata Nóra
Halmos, Gábor
Kapuvári, Bence
Kertész, István
Kőhalmy, Krisztina
Kőhidai, László
Lajkó, Eszter
Oláhné Szabó, Rita
Pethő, Lilla
Schlosser, Gitta Zsófia
Tóvári, József
Trencsényi, György
Starting date 2016-10-01
Closing date 2020-09-30
Funding (in million HUF) 47.950
FTE (full time equivalent) 19.30
state running project




Back »